first trust dsip portfolio (@ftportfolios) / Posts / X Direct Indexing Solutions - First

He came right to us

Scenario 2: Subcutaneous Biologic Administration for Chronic Disease Management ICD-10: M06.9 (Rheumatoid arthritis, unspecified) A patient with rheumatoid arthritis returns for a scheduled SC injection of a biologic agent (adalimumab)

if a calculated dose falls below 10 units, consider a smaller-capacity syringe for improved accuracy

With intramuscular (IM) injections the standard treatment for severe deficiency or malabsorption conditions like pernicious anaemiaserum B12 levels rise rapidly, typically reaching therapeutic ranges within 2448 hours after the first injection

Both are MHRA-approved, supported by large Phase 3 clinical trials, and available on prescription in the UK

As a histone deacetylase (HDAC) inhibitor, butyrate acts directly on B-cell intrinsic pathways without relying on GPR signaling or serving as an energy substrate